This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code describes only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0366U only for Oncuria® Monitor from DiaCarta Clinical Lab, DiaCarta Inc. Using immunoassay technique, the test evaluates a urine specimen for the levels of 10 protein biomarkers listed in the code and performs an algorithmic analysis to report the probability that a patient with prior bladder cancer has a recurrence of the cancer.
For clinical responsibility, terminology, tips and additional info
start codify free trial.